JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Pharmaceuticals
$165.50
+2.35 (+1.44%)
Performance
1D
—
1W
-1.07%
1M
+1.11%
3M
+20.71%
6M
+41.31%
1Y
+34.00%
YTD
-4.42%
Open$164.16
Previous Close$163.15
Day High$166.62
Day Low$164.16
52W High$182.99
52W Low$95.49
Volume703.4K
Avg Volume727.4K
Market Cap10.06B
P/E Ratio—
EPS$-6.07
SectorPharmaceuticals
Volume Analysis
0.97x average volume
Technical Indicators
SMA 50
$168.19
Below
SMA 200
$133.91
Above
RSI (14)
42
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
15 analysts
Price Target
+12.5% upside
Current
$165.50
$165.50
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 3.75B | 3.42B | 1.71B |
| Net Income | 515.64M | 423.58M | 431.71M |
| Profit Margin | 13.8% | 13.1% | 25.3% |
| EBITDA | 1.24B | 1.07B | 625.64M |
| Free Cash Flow | — | — | 246.64M |
| Rev Growth | +9.6% | +9.6% | +7.0% |
| Debt/Equity | 1.49 | 1.49 | 0.42 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |